182 related articles for article (PubMed ID: 17438583)
1. Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
Ustun C; Farrow S; DeRemer D; Fain H; Jillella AP
Bone Marrow Transplant; 2007 Jun; 39(12):807-8. PubMed ID: 17438583
[No Abstract] [Full Text] [Related]
2. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
Siwek GT; Dodgson KJ; de Magalhaes-Silverman M; Bartelt LA; Kilborn SB; Hoth PL; Diekema DJ; Pfaller MA
Clin Infect Dis; 2004 Aug; 39(4):584-7. PubMed ID: 15356827
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
[TBL] [Abstract][Full Text] [Related]
4. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation.
Mousset S; Bug G; Heinz WJ; Tintelnot K; Rickerts V
Transpl Infect Dis; 2010 Jun; 12(3):261-4. PubMed ID: 19954497
[TBL] [Abstract][Full Text] [Related]
6. Zygomycete infection following voriconazole prophylaxis.
van Well GT; van Groeningen I; Debets-Ossenkopp YJ; van Furth AM; Zwaan CM
Lancet Infect Dis; 2005 Sep; 5(9):594. PubMed ID: 16122683
[No Abstract] [Full Text] [Related]
7. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
Auberger J; Lass-Flörl C; Clausen J; Bellmann R; Buzina W; Gastl G; Nachbaur D
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):336-9. PubMed ID: 18687556
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Marty FM; Cosimi LA; Baden LR
N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
[No Abstract] [Full Text] [Related]
10. Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature.
Lekakis LJ; Lawson A; Prante J; Ribes J; Davis GJ; Monohan G; Baraboutis IG; Skoutelis AT; Howard DS
Biol Blood Marrow Transplant; 2009 Aug; 15(8):991-5. PubMed ID: 19589489
[TBL] [Abstract][Full Text] [Related]
11. Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
Lebeau O; Van Delden C; Garbino J; Robert J; Lamoth F; Passweg J; Chalandon Y
Transpl Infect Dis; 2010 Jun; 12(3):269-72. PubMed ID: 20163567
[TBL] [Abstract][Full Text] [Related]
12. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Vigouroux S; Morin O; Moreau P; Méchinaud F; Morineau N; Mahé B; Chevallier P; Guillaume T; Dubruille V; Harousseau JL; Milpied N
Clin Infect Dis; 2005 Feb; 40(4):e35-7. PubMed ID: 15712069
[TBL] [Abstract][Full Text] [Related]
13. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Tong SY; Peleg AY; Yoong J; Handke R; Szer J; Slavin M
Transpl Infect Dis; 2007 Sep; 9(3):241-3. PubMed ID: 17605752
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
Schlemmer F; Lagrange-Xélot M; Lacroix C; de La Tour R; Socié G; Molina JM
Bone Marrow Transplant; 2008 Oct; 42(8):551-2. PubMed ID: 18622416
[No Abstract] [Full Text] [Related]
17. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
de Mol P; Meis JF
Neth J Med; 2009 Jan; 67(1):25-8. PubMed ID: 19155544
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
20. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]